Beskrivelse
Krav
IPC-klasse
Fullmektig i Norge:
Org.nummer: 925400262
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2011.12.20, US 201161577817 P
CONDAMINES O ET AL: "New immunoassay for the mapping of neurofibrillary degeneration in Alzheimer's disease using two monoclonal antibodies against human paired helical filament tau proteins", NEUROSCIENCE LETTERS, LIMERICK, IE, vol. 192, no. 2, 9 June 1995 (1995-06-09), pages 81-84, XP002266004, ISSN: 0304-3940, DOI: 10.1016/0304-3940(95)11617-6 (B1)
WO-A2-2010/144711 (B1)
FRANCK R. PETRY ET AL: "Specificity of Anti-Tau Antibodies when Analyzing Mice Models of Alzheimer's Disease: Problems and Solutions", PLOS ONE, vol. 9, no. 5, 2 May 2014 (2014-05-02), page e94251, XP055207209, DOI: 10.1371/journal.pone.0094251 (B1)
GOEDERT M ET AL: "EPITOPE MAPPING OF MONOCLONAL ANTIBODIES TO THE PAIRED HELICAL FILAMENTS OF ALZHEIMER'S DISEASE: IDENTIFICATION OF PHOSPHORYLATIONSITES IN TAU PROTEIN", BIOCHEMICAL JOURNAL, PORTLAND PRESS LTD, GB, vol. 301, no. PART 03, 1 August 1994 (1994-08-01), pages 871-877, XP000996679, ISSN: 0264-6021 (B1)
HASEGAWA M ET AL: "CHARACTERIZATION OF MAB AP422, A NOVEL PHOSPHORYLATION-DEPENDENT MONOCLONAL ANTIBODY AGAINST TAU PROTEIN", FEBS LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 384, 1 January 1996 (1996-01-01), pages 25-30, XP000916614, ISSN: 0014-5793, DOI: 10.1016/0014-5793(96)00271-2 (B1)
HOFFMANN R ET AL: "Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites", BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 36, no. 26, 1 July 1997 (1997-07-01), pages 8114-8124, XP002625812, ISSN: 0006-2960, DOI: 10.1021/BI970380+ (B1)
JEAN-PIERRE BRION ET AL: "Neurofilament Monoclonal Antibodies RT97 and 8D8 Recognize Different Modified Epitopes in Paired Helical Filament-? in Alzheimer's Disease", JOURNAL OF NEUROCHEMISTRY, vol. 60, no. 4, 1 April 1993 (1993-04-01), pages 1372-1382, XP55207252, NEW YORK, NY, US ISSN: 0022-3042, DOI: 10.1111/j.1471-4159.1993.tb03298.x (B1)
JICHA GREGORY A ET AL: "A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease", JOURNAL OF NEUROCHEMISTRY, vol. 69, no. 5, 1997, pages 2087-2095, XP002743263, ISSN: 0022-3042 (B1)
MALIA THOMAS J ET AL: "Epitope mapping and structural basis for the recognition of phosphorylated tau by the anti-tau antibody AT8", PROTEINS STRUCTURE FUNCTION AND BIOINFORMATICS, vol. 84, no. 4, April 2016 (2016-04), pages 427-434, ISSN: 0887-3585(print) (B1)
MASATO HASEGAWA ET AL: "Characterization of Two Distinct Monoclonal Antibodies to Paired Helical Filaments: Further Evidence for Fetal-Type Phosphorylation of the ? in Paired Helical Filaments", JOURNAL OF NEUROCHEMISTRY, vol. 60, no. 6, 1 June 1993 (1993-06-01), pages 2068-2077, XP55207251, NEW YORK, NY, US ISSN: 0022-3042, DOI: 10.1111/j.1471-4159.1993.tb03491.x (B1)
MERCKEN ET AL.: 'Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes.' ACTA NEUROPATHOL. vol. 84, no. 3, 1992, pages 265 - 272, XP008049337 (B1)
PORZIG R ET AL: "Epitope mapping of mAbs AT8 and Tau5 directed against hyperphosphorylated regions of the human tau protein", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 358, no. 2, 29 June 2007 (2007-06-29) , pages 644-649, XP026422493, ISSN: 0006-291X, DOI: 10.1016/J.BBRC.2007.04.187 [retrieved on 2007-06-29] (B1)
SINGER D ET AL: "Neighbored phosphorylation sites as PHF-tau specific markers in Alzheimer's disease", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 346, no. 3, 4 August 2006 (2006-08-04), pages 819-828, XP024925390, ISSN: 0006-291X, DOI: 10.1016/J.BBRC.2006.05.201 [retrieved on 2006-08-04] (B1)
US-A1- 2007 048 785 (B1)
US-A1- 2009 142 261 (B1)
US-A1- 2009 169 547 (B1)
US-A1- 2011 059 093 (B1)
US-A1- 2011 077 224 (B1)
US-A1- 2011 118 299 (B1)
US-A1- 2012 087 861 (B1)
US-A1- 2012 276 009 (B1)
US-A9- 2011 143 443 (B1)
WO-A1-2009/017161 (B1)
WO-A1-93/08302 (B1)
WO-A1-95/17429 (B1)
WO-A1-96/04309 (B1)
DATABASE MEDLINE [Online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; 30 October 1995 (1995-10-30), KSIEZAK-REDING H ET AL: "Binding of Alz 50 depends on Phe8 in tau synthetic peptides and varies between native and denatured tau proteins.", Database accession no. NLM8593596 & KSIEZAK-REDING H ET AL: "Binding of Alz 50 depends on Phe8 in tau synthetic peptides and varies between native and denatured tau proteins.", BRAIN RESEARCH 30 OCT 1995, vol. 697, no. 1-2, 30 October 1995 (1995-10-30), pages 63-75, ISSN: 0006-8993 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Varsel om betaling av første årsavgift (3319) (PTEP2794654)
|
Utgående
EP Registreringsbrev (3210) (PTEP2794654)
|
Innkommende, AR321670605
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Neste fornyelse/årsavgift:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 13. avg. år (EP) | 2024.12.11 | 5460 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 12. avg. år (EP) | 2023.12.12 | 3850 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 11. avg. år (EP) | 2022.12.08 | 3500 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 10. avg. år (EP) | 2021.12.09 | 3200 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 9. avg. år (EP) | 2020.12.09 | 2850 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 8. avg. år (EP) | 2019.12.10 | 2550 | CPA GLOBAL LIMITED | Betalt og godkjent |
31909308 expand_more expand_less | 2019.06.24 | 5500 | OSLO PATENTKONTOR AS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|